157 related articles for article (PubMed ID: 25510412)
1. Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis.
Birtas Atesoglu E; Tarkun P; Demirsoy ET; Geduk A; Mehtap O; Batman A; Kaya F; Cekmen MB; Gulbas Z; Hacıhanefioglu A
Clin Appl Thromb Hemost; 2016 Apr; 22(3):248-51. PubMed ID: 25510412
[TBL] [Abstract][Full Text] [Related]
2. Percentages of PD-1
Wang Y; Pang N; Wang X; Liu Y; Wang X; Wang L; Sun M; Yasen H; Zhao F; Fan W; Guo X; Ding J
Hum Vaccin Immunother; 2018 Apr; 14(4):832-838. PubMed ID: 29333980
[TBL] [Abstract][Full Text] [Related]
3. Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP.
Zhong J; Chen S; Xu L; Lai J; Liao Z; Zhang T; Yu Z; Lu Y; Yang L; Wu X; Li B; Li Y
Hematology; 2016 Oct; 21(9):552-7. PubMed ID: 27077771
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients.
Dolasik I; Birtas Atesoglu E; Tarkun P; Mehtap O; Keski H; Dogru A; Hacihanefioglu A
Platelets; 2015; 26(3):220-3. PubMed ID: 24749912
[TBL] [Abstract][Full Text] [Related]
5. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
Luo L; Shu M; Li S; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
[TBL] [Abstract][Full Text] [Related]
6. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.
Yanaba K; Hayashi M; Yoshihara Y; Nakagawa H
J Dermatol; 2016 Aug; 43(8):954-7. PubMed ID: 26945563
[TBL] [Abstract][Full Text] [Related]
8. Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.
Aarslev K; Dige A; Greisen SR; Kreutzfeldt M; Jessen N; Vilstrup H; Deleuran B; Grønbæk H
Scand J Gastroenterol; 2017 Jan; 52(1):93-99. PubMed ID: 27604386
[TBL] [Abstract][Full Text] [Related]
9. Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer.
Zhang J; Zhang H; Luo Y
Med Sci Monit; 2019 Feb; 25():1275-1282. PubMed ID: 30771277
[TBL] [Abstract][Full Text] [Related]
10. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Greisen SR; Rasmussen TK; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Hvid M; Deleuran B
Scand J Rheumatol; 2014; 43(2):101-8. PubMed ID: 24182347
[TBL] [Abstract][Full Text] [Related]
11. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.
Fukasawa T; Yoshizaki A; Ebata S; Nakamura K; Saigusa R; Miura S; Yamashita T; Hirabayashi M; Ichimura Y; Taniguchi T; Asano Y; Shimizu H; Kazoe Y; Mawatari K; Kitamori T; Sato S
Arthritis Rheumatol; 2017 Sep; 69(9):1879-1890. PubMed ID: 28556548
[TBL] [Abstract][Full Text] [Related]
14. Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases.
Shi B; Du X; Wang Q; Chen Y; Zhang X
Metabolism; 2013 Jun; 62(6):778-85. PubMed ID: 23398844
[TBL] [Abstract][Full Text] [Related]
15. Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia.
Deng G; Yu S; Li Q; He Y; Liang W; Yu L; Xu D; Sun T; Zhang R; Li Q
Hematology; 2017 Apr; 22(3):155-161. PubMed ID: 27734765
[TBL] [Abstract][Full Text] [Related]
16. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.
Zhao Y; Jia Y; Li C; Shao R; Fang Y
Shock; 2019 Mar; 51(3):289-297. PubMed ID: 29702526
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of IL-33 in immune thrombocytopenia.
Li PP; Zhang XM; Yuan D; Liu X; Li Y; Shan NN
Int Immunopharmacol; 2015 Sep; 28(1):420-4. PubMed ID: 26164496
[TBL] [Abstract][Full Text] [Related]
19. [Effects of soluble programmed death ligand 1 on regulating the proliferation of T lymphocytes and its mechanism].
Zhao J; Pan X; Xing Y; Lu M; Chen Y; Shi M
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(6):449-52. PubMed ID: 25916783
[TBL] [Abstract][Full Text] [Related]
20. Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways.
Liu C; Jiang J; Gao L; Wang X; Hu X; Wu M; Wu J; Xu T; Shi Q; Zhang X
Arthritis Res Ther; 2015 Nov; 17():340. PubMed ID: 26608464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
